Cargando…
Response to Shami et al. ‘Evaluating the cost-effectiveness of a sequential pneumococcal vaccination compared to single dose vaccination strategy for adults in Hong Kong’ (Hum Vacc Immunother 2020)
The recently published article by Shami et al. describes a cost-effectiveness analysis of sequential pneumococcal vaccination with 13-valent pneumococcal conjugate vaccine (PCV13) followed by 23-valent pneumococcal polysaccharide vaccine (PPSV23), compared with a single PPSV23 dose, in adults in Hon...
Autores principales: | Buchwald, Ulrike K., Folaranmi, Temitope, Weiss, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877236/ https://www.ncbi.nlm.nih.gov/pubmed/32614654 http://dx.doi.org/10.1080/21645515.2020.1764828 |
Ejemplares similares
-
VaccImm: simulating peptide vaccination in cancer therapy
por: von Eichborn, Joachim, et al.
Publicado: (2013) -
Fattening performance and carcass traits of Baladi and Shami-Baladi kids
por: Obeidat, Mohammad D., et al.
Publicado: (2020) -
Persistence of Pneumococcal Serotype 3 in Adult Pneumococcal Disease in Hong Kong
por: Subramanian, Reema, et al.
Publicado: (2021) -
Response to Wu et al. — Cost-effectiveness analysis of infant pneumococcal vaccination in Malaysia and Hong Kong
por: Varghese, Lijoy, et al.
Publicado: (2016) -
Comparison of influenza disease burden in older populations of Hong Kong and Brisbane: the impact of influenza and pneumococcal vaccination
por: Yang, Lin, et al.
Publicado: (2019)